Income Statement MINAPHARM Pharmaceuticals

Stocks

MIPH

EGS380G1C011

Pharmaceuticals

End-of-day quote Egyptian Exchange 2026-10-01			5-day change	1st Jan Change
812.49 ^EGP	+4.21%		+0.32%	+132.67%

08-27	CEPI backs Minapharm's experimental Ebola vaccine with up to $16.5 million funding	RE
08-27	Minapharm Group Receives Funding to Advance Bundibugyo Ebolavirus Vaccine Candidate to Clinical Trials	CI

d519f.hGZGWxC37_RbFLKwlMu4rjnfE77JaWVx1xiLV8MFvcs.xi8wblf0gq4PduHfofqB1wzqV-_-JxdAkWzxBqcx_42xLR8TXOaFnwNA1Q

Published financial data: MINAPHARM PHARMACEUTICALS

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (EGP)	2022 (EGP)	2023 (EGP)	2024 (EGP)	2025 (EGP)
Revenues	3.01B	3.62B	3.89B	5.66B	6.44B
Total Revenues	3.01B	3.62B	3.89B	5.66B	6.44B
Cost of Goods Sold, Total	1.82B	2.12B	2.64B	3.73B	4.14B
Gross Profit	1.19B	1.5B	1.25B	1.94B	2.3B
Selling General & Admin Expenses, Total	393M	475M	719M	829M	1.04B
Provision for Bad Debts	186K	-2.67M	7.14M	42.62M	17.84M
R&D Expenses	45.84M	59.35M	151M	131M	225M
Other Operating Expenses, Total	439M	532M	877M	1B	1.28B
Operating Income	747M	965M	375M	934M	1.02B
Interest Expense, Total	-48.84M	-62.17M	-254M	-594M	-749M
Interest And Investment Income	5.08M	9.55M	14.06M	46.56M	63.88M
Net Interest Expenses	-43.76M	-52.63M	-240M	-547M	-685M
Currency Exchange Gains (Loss)	-1.76M	37.52M	-37.3M	10.67M	-21.14M
Other Non Operating Income (Expenses)	-33.2M	-69.29M	-63.76M	-117M	-98.57M
EBT, Excl. Unusual Items	668M	880M	33.2M	280M	214M
Gain (Loss) On Sale Of Assets	459K	-5.2K	-169K	-449K	-153K
Asset Writedown	-	-	-	-	-
EBT, Incl. Unusual Items	668M	880M	33.03M	280M	214M
Income Tax Expense	193M	249M	10.67M	119M	167M
Earnings From Continuing Operations	475M	631M	22.36M	161M	47.2M
Net Income to Company	475M	631M	22.36M	161M	47.2M
Minority Interest	-8.46M	-18.23M	-54.35M	-4.04M	-6.98M
Net Income - (IS)	466M	613M	-31.99M	157M	40.22M
Preferred Dividend and Other Adjustments	18.7M	22.75M	23.4M	28.91M	33.6M
Net Income to Common Incl Extra Items	448M	590M	-55.39M	128M	6.62M
Net Income to Common Excl. Extra Items	448M	590M	-55.39M	128M	6.62M
Per Share Items
Net EPS - Basic	36.42	51.41	-5.01	11.58	0.6
Basic EPS - Continuing Operations	36.42	51.41	-5.01	11.58	0.6
Basic Weighted Average Shares Outstanding	12.29M	11.47M	11.06M	11.06M	11.06M
Net EPS - Diluted	36.42	51.41	-5.01	11.58	0.6
Diluted EPS - Continuing Operations	36.42	51.41	-5.01	11.58	0.6
Diluted Weighted Average Shares Outstanding	12.29M	11.47M	11.06M	11.06M	11.06M
Normalized Basic EPS	33.26	46.36	-3.04	15.46	11.47
Normalized Diluted EPS	33.26	46.36	-3.04	15.46	11.47
Dividend Per Share	2.92	2.8	1.65	2.5	-
Payout Ratio	10.68	9.43	-168.4	25.57	149.97
Supplemental Items
EBITDA	828M	1.09B	536M	1.17B	1.35B
EBITA	750M	970M	381M	960M	1.05B
EBIT	747M	965M	375M	934M	1.02B
EBITDAR	-	-	-	-	1.36B
Effective Tax Rate - (Ratio)	28.94	28.34	32.29	42.39	77.94
Total Current Taxes	187M	232M	42.06M	101M	157M
Total Deferred Taxes	6.46M	17.39M	-31.39M	17.7M	9.67M
Normalized Net Income	409M	532M	-33.6M	171M	127M
Interest on Long-Term Debt	484K	2.98M	-	-	231M
Supplemental Operating Expense Items
Advertising Expense	-	8.4M	14.12M	-	25.66M
Selling and Marketing Expenses	223M	267M	375M	374M	420M
General and Administrative Expenses	169M	208M	343M	455M	618M
Research And Development Expense From Footnotes	45.84M	59.35M	151M	131M	275M
Net Rental Expense, Total	-	-	-	-	11.85M
Imputed Operating Lease Interest Expense	-	-	-	-	14.03M
Imputed Operating Lease Depreciation	-	-	-	-	-2.18M
Maintenance & Repair Expenses, Total	-	-	-	-	64.53M

Fiscal Period: December	2021 (EGP)	2022 (EGP)	2023 (EGP)	2024 (EGP)	2025 (EGP)
Assets
Cash And Equivalents	982M	1.69B	1.92B	2.89B	3.43B
Short Term Investments	-	-	-	5M	-
Total Cash And Short Term Investments	982M	1.69B	1.92B	2.89B	3.43B
Accounts Receivable, Total	389M	478M	493M	648M	510M
Other Receivables	5.52M	12.22M	17.56M	76.37M	993K
Notes Receivable	5.31M	84.71M	204M	281M	144M
Total Receivables	400M	575M	714M	1.01B	655M
Inventory	669M	838M	1.05B	1.23B	1.49B
Prepaid Expenses	6.54M	12.41M	10.76M	30.33M	41.07M
Other Current Assets, Total	346M	525M	344M	559M	633M
Total Current Assets	2.4B	3.64B	4.04B	5.72B	6.25B
Gross Property Plant And Equipment	2.04B	3.62B	5.49B	7.56B	8.4B
Accumulated Depreciation	-701M	-934M	-1.24B	-1.87B	-2.25B
Net Property Plant And Equipment	1.34B	2.69B	4.25B	5.69B	6.15B
Long-term Investments	5M	5M	5M	-	5M
Goodwill	221M	280M	335M	340M	355M
Other Intangibles, Total	48.2M	56.9M	67.1M	255M	376M
Deferred Tax Assets Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	89.77M	135M	3.22M	4.92M	5.22M
Total Assets	4.11B	6.81B	8.7B	12B	13.15B
Liabilities
Accounts Payable, Total	417M	677M	708M	1.16B	1.19B
Accrued Expenses, Total	31.53M	39.23M	46.81M	47.34M	110M
Short-term Borrowings	542M	1.04B	2.07B	2.22B	2.02B
Current Portion of Long-Term Debt	32.93M	225M	219M	398M	707M
Current Portion of Leases	68.13M	15.1M	27.77M	55.35M	49.42M
Current Income Taxes Payable	184M	233M	135M	196M	255M
Unearned Revenue Current, Total	5.04M	7.45M	9.81M	14.62M	17.25M
Other Current Liabilities	209M	261M	315M	495M	457M
Total Current Liabilities	1.49B	2.5B	3.53B	4.59B	4.81B
Long-Term Debt	604M	1.04B	1.34B	2.25B	1.5B
Long-Term Leases	1.17M	115M	154M	563M	260M
Unearned Revenue Non Current	-	-	-	168M	195M
Deferred Tax Liability Non Current	22.69M	56.01M	44.99M	27.54M	24.86M
Other Non Current Liabilities	45.73M	57.52M	121M	-	-
Total Liabilities	2.16B	3.77B	5.19B	7.59B	6.79B
Common Stock, Total	123M	123M	123M	118M	118M
Retained Earnings	1.47B	2.02B	2.15B	2.05B	4.09B
Treasury Stock	-	-69.63M	-69.63M	-	-
Comprehensive Income and Other	293M	883M	1.22B	2.14B	2.05B
Total Common Equity	1.88B	2.96B	3.42B	4.31B	6.25B
Minority Interest	61.29M	81.82M	94.61M	103M	108M
Total Equity	1.94B	3.04B	3.52B	4.41B	6.36B
Total Liabilities And Equity	4.11B	6.81B	8.7B	12B	13.15B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	12.29M	11.06M	11.06M	11.78M	11.78M
ECS Total Common Shares Outstanding	12.29M	11.06M	11.06M	11.78M	11.78M
Book Value / Share	153.07	267.42	309.35	365.53	530.56
Tangible Book Value	1.61B	2.62B	3.02B	3.71B	5.52B
Tangible Book Value Per Share	131.21	236.96	273.05	315.04	468.49
Total Debt	1.25B	2.43B	3.81B	5.49B	4.54B
Net Debt	266M	740M	1.89B	2.6B	1.11B
Debt Equivalent Oper. Leases	-	-	-	-	94.8M
Minority Interest, Total (Incl. Fin. Div)	61.29M	81.82M	94.61M	103M	108M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	411M	609M	762M	887M	1.01B
Inventories - Work In Process, Total	58.47M	46.99M	42.82M	44.48M	85.57M
Inventories - Finished Goods, Total	158M	131M	172M	184M	261M
Inventories - Others	52.05M	64.11M	100M	143M	178M
Land - (BS)	26.15M	-	39.7M	55.2M	57.96M
Buildings, Total	297M	-	509M	1.58B	1.7B
Machinery, Total	978M	-	1.78B	2.5B	3.25B
Accumulated Allowance for Doubtful Accounts (Supple)	10.9M	10.63M	24.13M	63.27M	83.27M

Fiscal Period: December	2021 (EGP)	2022 (EGP)	2023 (EGP)	2024 (EGP)	2025 (EGP)
Net Income	466M	613M	-31.99M	157M	40.22M
Depreciation & Amortization - CF	82.88M	128M	186M	259M	348M
Amortization of Goodwill and Intangible Assets - (CF)	3.1M	4.95M	6.6M	25.95M	32.49M
Depreciation & Amortization, Total	85.99M	133M	192M	285M	380M
(Gain) Loss From Sale Of Asset	-459K	-	169K	5.67M	153K
Asset Writedown & Restructuring Costs	-	-	-	-	-
Provision and Write-off of Bad Debts	-8.91M	-2.67M	15.98M	39.15M	20M
Other Operating Activities, Total	89.43M	81.64M	-88.92M	160M	18.86M
Change In Accounts Receivable	-22.41M	-169M	-147M	-271M	280M
Change In Inventories	-83.29M	-171M	-226M	-181M	-278M
Change In Accounts Payable	-91.57M	265M	39.82M	266M	-58.45M
Change in Other Net Operating Assets	-229M	-188M	352M	-238M	62.11M
Cash from Operations	206M	562M	106M	222M	465M
Capital Expenditure	-388M	-1.16B	-1.4B	-919M	-788M
Sale of Property, Plant, and Equipment	761K	-	169K	-	-
Sale (Purchase) of Intangible assets	-1.82M	-2.03M	-10.65M	-92.93K	-3.94M
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	300M	-
Other Investing Activities, Total	-5.92K	2.37K	1.26K	45.26M	63.88M
Cash from Investing	-389M	-1.16B	-1.41B	-574M	-728M
Short Term Debt Issued, Total	-	495M	1.02B	2.5B	5.96B
Long-Term Debt Issued, Total	426M	637M	356M	1.38B	909M
Total Debt Issued	426M	1.13B	1.38B	3.88B	6.87B
Short Term Debt Repaid, Total	-205M	-	-	-2.23B	-6.39B
Long-Term Debt Repaid, Total	-11.86M	-12.15M	-25.52M	-293M	-1.87B
Total Debt Repaid	-217M	-12.15M	-25.52M	-2.52B	-8.26B
Issuance of Common Stock	-	-	-	-	2.17B
Repurchase of Common Stock	-	-69.63M	-	-	-
Common Dividends Paid	-49.8M	-57.79M	-53.87M	-40.16M	-60.31M
Common & Preferred Stock Dividends Paid	-49.8M	-57.79M	-53.87M	-40.16M	-60.31M
Other Financing Activities, Total	-3.2M	2.31M	216M	-	-27.47M
Cash from Financing	156M	994M	1.51B	1.32B	699M
Foreign Exchange Rate Adjustments	-13.97M	318M	15.2M	5.49M	33.06M
Miscellaneous Cash Flow Adjustments	-	1	-	-	-
Net Change in Cash	-41.56M	712M	224M	969M	469M
Supplemental Items
Cash Interest Paid	48.84M	62.17M	254M	594M	749M
Cash Income Tax Paid (Refund)	155M	182M	133M	26.07M	76.84M
Levered Free Cash Flow	-144M	-623M	-1.32B	-427M	-184M
Unlevered Free Cash Flow	-114M	-584M	-1.16B	-55.87M	284M
Change In Net Working Capital	276M	157M	179M	5.18M	-59.21M
Net Debt Issued / Repaid	209M	1.12B	1.35B	1.36B	-1.39B

Fiscal Period: December	2021 (EGP)	2022 (EGP)	2023 (EGP)	2024 (EGP)	2025 (EGP)
Profitability
Return on Assets	12.3	11.05	3.02	5.64	5.06
Return on Total Capital	16.25	13.92	3.66	6.78	6.13
Return On Equity %	26.86	25.32	0.68	4.07	0.89
Return on Common Equity	26.19	24.37	-1.74	3.32	0.13
Margin Analysis
Gross Profit Margin %	39.44	41.33	32.16	34.19	35.73
SG&A Margin	13.07	13.12	18.46	14.63	16.14
EBITDA Margin %	27.57	29.99	13.77	20.69	20.94
EBITA Margin %	24.94	26.78	9.8	16.94	16.33
EBIT Margin %	24.84	26.65	9.63	16.49	15.82
Income From Continuing Operations Margin %	15.8	17.43	0.57	2.84	0.73
Net Income Margin %	15.52	16.92	-0.82	2.77	0.62
Net Avail. For Common Margin %	14.9	16.29	-1.42	2.26	0.1
Normalized Net Income Margin	13.61	14.69	-0.86	3.02	1.97
Levered Free Cash Flow Margin	-4.79	-17.2	-33.92	-7.54	-2.85
Unlevered Free Cash Flow Margin	-3.78	-16.12	-29.84	-0.99	4.42
Asset Turnover
Asset Turnover	0.79	0.66	0.5	0.55	0.51
Fixed Assets Turnover	2.56	1.8	1.12	1.14	1.09
Receivables Turnover (Average Receivables)	8.34	8.35	8.02	9.93	11.13
Inventory Turnover (Average Inventory)	2.9	2.82	2.79	3.26	3.03
Short Term Liquidity
Current Ratio	1.61	1.46	1.14	1.25	1.3
Quick Ratio	0.92	0.87	0.69	0.79	0.82
Operating Cash Flow to Current Liabilities	0.14	0.22	0.03	0.05	0.1
Days Sales Outstanding (Average Receivables)	43.76	43.7	45.53	36.84	32.8
Days Outstanding Inventory (Average Inventory)	125.91	129.46	130.86	112.29	120.29
Average Days Payable Outstanding	88.79	87.03	88.45	87.39	100.05
Cash Conversion Cycle (Average Days)	80.89	86.12	87.93	61.74	53.04
Long Term Solvency
Total Debt/Equity	64.25	80.02	108.22	124.48	71.4
Total Debt / Total Capital	39.12	44.45	51.97	55.45	41.66
LT Debt/Equity	31.14	37.86	42.34	63.79	27.73
Long-Term Debt / Total Capital	18.96	21.03	20.33	28.42	16.18
Total Liabilities / Total Assets	52.67	55.32	59.59	63.27	51.64
EBIT / Interest Expense	15.28	15.52	1.47	1.57	1.36
EBITDA / Interest Expense	17.05	17.65	2.23	2.05	1.87
(EBITDA - Capex) / Interest Expense	9.1	-1.01	-3.27	0.5	0.82
Total Debt / EBITDA	1.5	2.22	6.71	4.5	3.25
Net Debt / EBITDA	0.32	0.67	3.33	2.13	0.79
Total Debt / (EBITDA - Capex)	2.81	-38.85	-4.58	18.32	7.43
Net Debt / (EBITDA - Capex)	0.6	-11.81	-2.27	8.67	1.82
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	27.29	20.47	7.5	45.55	14.97
Gross Profit, 1 Yr. Growth %	31.05	26.24	-16.36	54.74	19.07
EBITDA, 1 Yr. Growth %	33.26	29.9	-50.64	118.68	15.01
EBITA, 1 Yr. Growth %	38.54	28.09	-60.68	151.75	9.51
EBIT, 1 Yr. Growth %	38.55	27.96	-61.17	149.25	9.08
Earnings From Cont. Operations, 1 Yr. Growth %	52.85	32.86	-96.46	620.37	-70.71
Net Income, 1 Yr. Growth %	55.07	31.36	-105.22	-591.01	-74.4
Normalized Net Income, 1 Yr. Growth %	57.23	30.1	-106.32	-608.97	-25.83
Diluted EPS Before Extra, 1 Yr. Growth %	56.95	41.17	-109.74	-331.37	-94.84
Accounts Receivable, 1 Yr. Growth %	17.13	22.99	3.09	31.37	-21.3
Inventory, 1 Yr. Growth %	13.86	25.39	25.85	16.83	21.27
Net Property, Plant and Equip., 1 Yr. Growth %	33.47	100.42	58.33	33.76	8.22
Total Assets, 1 Yr. Growth %	17.88	65.77	27.88	37.91	9.47
Tangible Book Value, 1 Yr. Growth %	29.57	62.54	15.23	22.85	53.64
Common Equity, 1 Yr. Growth %	22.41	57.24	15.68	25.82	49.27
Cash From Operations, 1 Yr. Growth %	-52.92	171.02	-81.19	116.44	109.83
Capital Expenditures, 1 Yr. Growth %	158.08	199.12	20.51	-34.11	-14.27
Levered Free Cash Flow, 1 Yr. Growth %	-151.96	346.56	112.05	-67.58	-49.41
Unlevered Free Cash Flow, 1 Yr. Growth %	-135.42	436.05	98.92	-95.17	3.42K
Dividend Per Share, 1 Yr. Growth %	8.22	-4.17	-41.07	51.52	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	21.05	23.83	13.8	25.08	28.62
Gross Profit, 2 Yr. CAGR %	35.45	28.62	2.76	13.76	35.57
EBITDA, 2 Yr. CAGR %	51.57	32.16	-19.92	3.9	58.59
EBITA, 2 Yr. CAGR %	58.88	33.87	-29.04	-0.51	66.04
EBIT, 2 Yr. CAGR %	58.89	33.81	-29.51	-1.61	64.89
Earnings From Cont. Operations, 2 Yr. CAGR %	78.88	42.5	-78.3	-49.47	45.27
Net Income, 2 Yr. CAGR %	81.82	42.72	-73.81	-49.37	12.12
Normalized Net Income, 2 Yr. CAGR %	82.54	43.02	-71.33	-43.3	94.3
Diluted EPS Before Extra, 2 Yr. CAGR %	78.13	48.86	-62.92	-52.54	-65.44
Accounts Receivable, 2 Yr. CAGR %	39.37	20.02	12.6	16.37	1.68
Inventory, 2 Yr. CAGR %	17.86	19.49	25.62	21.26	19.03
Net Property, Plant and Equip., 2 Yr. CAGR %	22.02	63.55	78.14	45.53	20.31
Total Assets, 2 Yr. CAGR %	19.16	39.79	45.6	32.8	22.91
Tangible Book Value, 2 Yr. CAGR %	27.37	45.12	36.86	18.98	35.16
Common Equity, 2 Yr. CAGR %	21.18	38.74	34.87	20.64	35.14
Cash From Operations, 2 Yr. CAGR %	-0.01	13.36	-28.59	-37.21	113.11
Capital Expenditures, 2 Yr. CAGR %	26.04	177.85	89.86	-11	-24.85
Levered Free Cash Flow, 2 Yr. CAGR %	30.04	49.84	207.72	-17.19	-62.66
Unlevered Free Cash Flow, 2 Yr. CAGR %	113.4	34.94	226.55	-69.06	-50.45
Dividend Per Share, 2 Yr. CAGR %	-	1.84	-24.85	-5.51	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	16.13	20.86	18.13	23.53	21.15
Gross Profit, 3 Yr. CAGR %	23.77	32.31	11.43	17.78	15.41
EBITDA, 3 Yr. CAGR %	36.4	44.41	-4.82	11.93	7.48
EBITA, 3 Yr. CAGR %	38.54	48.36	-11.01	8.23	2.72
EBIT, 3 Yr. CAGR %	40.39	48.32	-11.41	7.39	1.83
Earnings From Cont. Operations, 3 Yr. CAGR %	56.35	61.99	-58.4	-30.25	-57.86
Net Income, 3 Yr. CAGR %	58.83	63.15	-52.62	-30.43	-59.66
Normalized Net Income, 3 Yr. CAGR %	57.05	63.05	-49.44	-25.21	-37.99
Diluted EPS Before Extra, 3 Yr. CAGR %	56.68	64.85	-40.02	-31.74	-77.34
Accounts Receivable, 3 Yr. CAGR %	31.5	33.68	14.09	18.54	2.15
Inventory, 3 Yr. CAGR %	10.26	20.32	21.57	22.62	21.26
Net Property, Plant and Equip., 3 Yr. CAGR %	17.67	43.97	61.79	61.91	31.84
Total Assets, 3 Yr. CAGR %	14.48	33.02	35.7	42.99	24.54
Tangible Book Value, 3 Yr. CAGR %	16.73	38.16	34.38	32.02	28.16
Common Equity, 3 Yr. CAGR %	12.59	32.18	30.58	31.78	28.31
Cash From Operations, 3 Yr. CAGR %	-14.91	39.75	-37.7	2.24	-6.12
Capital Expenditures, 3 Yr. CAGR %	4.46	68.12	110.32	33.31	-12.11
Levered Free Cash Flow, 3 Yr. CAGR %	73.01	94.06	68.23	45.21	-33.44
Unlevered Free Cash Flow, 3 Yr. CAGR %	36.41	186.06	53.57	-19.95	-21.32
Dividend Per Share, 3 Yr. CAGR %	-24.35	-	-15.14	-5.06	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	23.76	17.08	15.19	22.53	22.22
Gross Profit, 5 Yr. CAGR %	29.98	20.11	14.89	24.55	20.53
EBITDA, 5 Yr. CAGR %	38.65	22.6	10.42	26.59	16.74
EBITA, 5 Yr. CAGR %	44.02	22.64	6.22	26.44	14.2
EBIT, 5 Yr. CAGR %	47.23	23.47	6.79	25.86	13.58
Earnings From Cont. Operations, 5 Yr. CAGR %	58.6	27.25	-29.03	1.66	-31.4
Net Income, 5 Yr. CAGR %	69.89	28.42	-22.77	2.17	-33.13
Normalized Net Income, 5 Yr. CAGR %	58.35	28.91	-20.46	6.86	-13.37
Diluted EPS Before Extra, 5 Yr. CAGR %	68.51	29.23	-11.97	0.18	-51.89
Accounts Receivable, 5 Yr. CAGR %	23	21.44	23.59	26.47	8.95
Inventory, 5 Yr. CAGR %	20.3	8.47	16.17	20.7	20.55
Net Property, Plant and Equip., 5 Yr. CAGR %	36.55	37.8	38.9	44.59	43.71
Total Assets, 5 Yr. CAGR %	15.24	20.19	26.04	32.93	30.43
Tangible Book Value, 5 Yr. CAGR %	13.72	21.25	24.4	30.14	34.7
Common Equity, 5 Yr. CAGR %	11.76	18.95	21.02	27.44	32.38
Cash From Operations, 5 Yr. CAGR %	-13.95	172.26	-20.56	1.48	1.24
Capital Expenditures, 5 Yr. CAGR %	46.11	32.17	32.66	30.35	39.28
Levered Free Cash Flow, 5 Yr. CAGR %	22.63	13.42	116.39	38.03	-7.91
Unlevered Free Cash Flow, 5 Yr. CAGR %	10.21	15.89	91.8	17.51	-2.38
Dividend Per Share, 5 Yr. CAGR %	-8.28	17.5	-24.55	-	-